Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 500,508 |
|
|||||
| News | - | ||||||
| Day High | 40.08 | Low High |
|||||
| Day Low | 37.51 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Corbus Pharmaceuticals Holdings Inc | CRBP | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.04 | 0.11% | 37.74 | 18:02:26 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 37.83 | 37.51 | 40.08 | 37.74 | 37.70 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 5,705 | 500,508 | $ 38.89 | $ 19,463,932 | - | 3.0334 - 49.8699 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:52:02 | 3 | $ 37.74 | USD |
Corbus Pharmaceuticals (CRBP) Options Flow Summary
Corbus Pharmaceuticals Holdings Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 396.11M | 10.49M | - | 0 | -44.6M | -4.25 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Corbus Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CRBP Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 42.71 | 45.00 | 35.19 | 38.68 | 254,505 | -4.97 | -11.64% |
| 1 Month | 35.42 | 45.00 | 33.2398 | 38.91 | 225,101 | 2.32 | 6.55% |
| 3 Months | 21.29 | 49.8699 | 19.34 | 32.65 | 413,593 | 16.45 | 77.27% |
| 6 Months | 6.00 | 49.8699 | 3.0334 | 29.49 | 498,460 | 31.74 | 529.00% |
| 1 Year | 9.28 | 49.8699 | 3.0334 | 28.60 | 261,238 | 28.46 | 306.68% |
| 3 Years | 52.716 | 68.70 | 2.11 | 19.98 | 1,310,484 | -14.98 | -28.41% |
| 5 Years | 207.60 | 322.50 | 2.11 | 65.00 | 2,196,838 | -169.86 | -81.82% |
Corbus Pharmaceuticals Description
| Corbus Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics for endocannabinoid or immune system. The company's lead product candidate, lenabasum, is a novel, synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and fibrotic processes. Lenabasum is currently being evaluated in systemic sclerosis, cystic fibrosis, dermatomyositis, and systemic lupus erythematosus. |
